Objective: The study aims to present the clinical and demographic profile of subjects who have undergone Auditory Brainstem Response (ABR) test at the Philippine Children's Medical Center over a 10-year period.
hearing screening programs, or when hearing was tested because of concerns regarding speech, language and cognitive delays. The Joint Committee of Infant Hearing Year 2000 proposed that all infants born with hearing loss be screened by 1 month of age, diagnosed by 3 months and enrolled into early intervention by 6 months of age. This strong recommendation for early detection and intervention for infants with hearing loss cannot be overemphasized, as Yoshinaga-Itano and colleagues 7 showed that children in whom hearing loss was identified, and remediation instituted before 6 months of age had significantly higher scores on tests of vocabulary, expressive language and language comprehension than those diagnosed after 6 months. The screening tools of choice for newborns include Oto-acoustic Emission (OAE) and Auditory Brainstem Evoked Response (ABR) tests, with the latter being more reliable for the difficult to test and for very young patients.
As one of the first local institutions to acquire an Auditory Brainstem Response (ABR) machine, the Philippine Children's Medical Center (PCMC) has tested children from all over the country for the past 13 years. The study aims to present the clinical and demographic profile of subjects who have undergone Auditory Brainstem Response (ABR) test at the Philippine Children's Medical Center over a 10-year period.
RESEARCH OBJECTIVES General Objective:
To present the clinical and demographic profile of subjects who have undergone ABR test at PCMC from January 1996 to December 2005.
Specific Objectives:
1. To present ABR patient distribution as to age, sex, working diagnosis (pertinent to ABR testing/ reason for referral), source of referral (physician's specialty); 2. To determine the incidence and degree of auditory pathway pathology for the ten most common working diagnoses/indications for ABR referral and compare them with existing international literature; 3. To rank the leading causes of referral for each age group over the 10-year period;
4. To determine the average age of auditory pathology detection by ABR among patients presenting with speech delay over the 10-year period;
5. To determine if there is a significant difference in the degree of hearing loss detected during the preschool (2-5 years old) and school age (more than 5 years old) group of patients with speech delay;
6. To determine the number of subjects 3 months and younger referred specifically for hearing screening and with no indicated risk factor/s for hearing loss; and 7. To present the most common reasons for referrals and degree of hearing loss in the neonatal age group. The average age of auditory pathology detection was determined by taking the total age in months of the affected patients at the time of detection divided by the total number of affected patients.
Operational Definition of Terms

RESULTS
A total of 2783 patients were included in the study with an overall female to male ratio of 1:1.63 (Table 1 ). The 2-to-5 year-old age group was largest, making up 49% ( Figure I ). There were 111 total listed indications for referral. Close to 85% of the total cases were shared by the top 10 clinical entities; of these, 38% were represented by the Speech Delay Disorders (Appendix I, Figure 2 ). The remaining 15 % were shared by 101 other indications. Sixty-one percent of the referring physicians were residents and fellows, child neurology consultants contributed sixteen percent 16% followed by neurodevelopmental pediatricians and otolaryngologists with 8 and 4%, respectively (Figure3).
The incidence and degree of pathologic ABR results for the 10 leading indications are listed in table 2. Table 3 shows comparative results with selected foreign studies on these 10 indications of referral. No direct comparison could be found in published studies regarding ABR results of patients with seizure disorder per se and patients primarily suspected for hearing loss. Table 4 shows the most common causes for ABR referral for each age group. Global developmental delay was the primary reason for referrals in subjects under 2 years old, followed by speech delay. Bacterial meningitis was also a notable cause in this age group. Speech delay was the leading indication for ages 2-10 years old while hearing loss dominated the older age group.
The overall average age of auditory pathology detection in speechdelayed patients was 46.48 months, with no trend observed in the yearly average age of auditory pathology detection except for a peak in 2002 (Appendix 2, Figure 4 ). For all degrees of hearing loss, there was a slight increase in the >5-10-year-old age group compared to the 2-5-year-old age group (Table 5 ). These differences were not statistically significant using the z-test of association (Appendix 3a, 3b). There were 57 (2%) patients aged 3 months and younger in the study, 4 of these were well babies, specifically referred for hearing screening. It is interesting to note that in patients 6 months and under, 7 were referred as follow ups to a "refer" result of a previous otoacoustic emission test.
Only 6 (0.22%) neonates were referred, 2 for aural atresia and 1 each for bacterial meningitis, prematurity, cerebral palsy and sepsis.
DISCUSSION
Speech and developmental delays were the leading causes for ABR referral across age groups with most (almost 50%) belonging to the 2-to-5-year-old age group. Because intelligible speech is expected from a child of this age, verbal delay prompts parents and guardians to consult. Abnormal ABR results for speech delay in our study were more than twice those of a European study. 8 Congenital Rubella syndrome presented with the highest incidence of abnormal ABR results at 90.62 %, slightly higher than that published by Roizen in 1999 9 while Niedzielska 10 and Sadijhi, J. et al 11 reported a much lower incidence. Our results for hearing loss in children with global developmental delay fell within the wide range of other studies exemplified by Haggard 12 and Rupa. 13 Our incidences for autism were 5.28% and 2.97% for mild to moderate, and severe to profound hearing loss, respectively, lower than the 7.9% and 3.5% reported by Rosenhall 14 in a European population. Taylor 15 similarly showed a higher incidence in his study considering only autistic children without associated features.
Bacterial meningitis was the most common reason among the infectious causes for ABR referral. The incidence of hearing loss as a sequel of bacterial meningitis were reported at 10% by Tarlow 16 and 7% by Koomen, 17 much lower than our results which were similar to those conducted at a children's hospital in Nepal. 18 Our results of more than 50% abnormal ABR in Down syndrome support the consistently high incidence of hearing impairment in this clinical entity as diagnosed by ABR. 19, 20 We had a 44.55% incidence of abnormal ABR in cerebral palsy patients, twice higher than the findings of Robinson 21 and Zafeiriou 22 and much higher than the 2-6% average incidence of hearing loss in the preterm infant population reported elsewhere. 23 It is possible that co-morbid conditions in a majority of our patients with cerebral palsy may have increased the incidence of abnormal ABR results. While the incidence of abnormal ABR results for developmental delays, post bacterial meningitis, Down syndrome and congenital Rubella were at par with foreign statistics, our incidence for autism was slightly lower. The myriad etiologies for, and different classifications of seizure disorders precluded making any direct comparisons with the literature.
No trend was noted on the average age of hearing loss detected in speech-delayed patients with respect to time; the peak average in year 2000 was attributed to an adult patient tested. Our results showed that we are 21 to 34 months behind the world's average age of detecting hearing loss in the pediatric population using speech delay as the presenting symptom. Reasons for late consultation may include a lack of awareness of the early signs of hearing loss on the part of parents and guardians. On the other hand, significant observations of concerned parents may have been disregarded by well-meaning health care givers who downplayed the possibility of hearing loss. Costs associated with hearing screening may also contribute to delay. Although it may be posted that a more severe degree of hearing loss in younger patients prompts earlier referral than among school-aged children in whom it was usually an incidental finding, this was not the case in our study. Further, there was no statistically significant difference in the degree of hearing loss between the preschool and school age groups with speech delay. Less than 1% of the overall indications for referral were for follow-up of failed hearing screening and only 2% of the subjects were 3 months old and younger. These values may reflect the minimal usage of ABR for hearing screening in our institution as well as a lack of awareness of the importance of newborn hearing screening in general. This may be exacerbated by the absence of a mandate to screen all newborns for potential hearing loss, and not just the high risk group as traditionally done. An important study among patients with congenital hearing loss showed that 50% did not have any risk factors. 24 Apart from delayed cognitive complications of hearing loss, economic and societal repercussions are not to be disregarded. It is estimated in an American study that households lose $122 billion in lost income and reduced federal tax revenues by another $18.4 billion. 25 ABR in hearing screening of neonates and children constitutes only a small fraction of the total indications for ABR Testing at the Philippine Children's Medical Center. Detection of hearing loss at an earlier age may reveal the true burden of illness and facilitate earlier intervention. Finally, to improve on the poor average age of hearing loss detection so that subsequent remedial measures are administered, it is strongly recommended that universal hearing screening be performed for all newborns and not just for high risk infants.
